Your browser doesn't support javascript.
loading
Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023.
Ali, Saghir; Bolinger, Andrew A; Zhou, Jia.
Afiliação
  • Ali S; Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, 77555, United States.
  • Bolinger AA; Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, 77555, United States.
  • Zhou J; Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, 77555, United States.
Curr Top Med Chem ; 24(10): 843-849, 2024.
Article em En | MEDLINE | ID: mdl-38445700
ABSTRACT
Fluorine continues to show its potential applications in drug discovery and development, as reflected by twelve drugs being fluorinated out of the fifty-five approved by the FDA in 2023. This concise review highlights the discovery of each of these fluorine-containing drugs in the past year, including its brand name, date of approval, composition, sponsors, indication, and mechanism of action. The relevant future trend is also briefly discussed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Aprovação de Drogas / Flúor Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Curr Top Med Chem Assunto da revista: QUIMICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Aprovação de Drogas / Flúor Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Curr Top Med Chem Assunto da revista: QUIMICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos